Afuco™ Anti-Human PSCA ADCC Therapeutic Antibody (AGS-1C4D4), ADCC Enhanced

Anti-PSCA ADCC Enhanced Antibody (AGS-1C4D4) is an ADCC enhanced antibody produced by our Afuco™ platform. AGS-1C4D4 is a human monoclonal antibody against prostate stem cell antigen (PSCA), which is a cell-surface protein expressed by most prostate cancers. Preclinical studies demonstrated the pruduct has tumor inhibition function. A limited Phase I trial using AGS-1C4D4 was performed evaluating safety and PK.
Supplier Creative Biolabs
Product # AFC-701CL
Pricing Inquiry
Host Human
Target PSCA
Species Reactivity Human
Type ADCC enhanced antibody
Applications FuncS
Storage Store at -20°C. Open under aseptic conditions.
Feedback